These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20501960)

  • 41. Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects.
    Niwa Y; Matsuo K; Ito H; Hirose K; Tajima K; Nakanishi T; Nawa A; Kuzuya K; Tamakoshi A; Hamajima N
    Gynecol Oncol; 2005 Oct; 99(1):43-9. PubMed ID: 15990162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
    Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
    Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphic variants INSIG2 rs6726538, HLA-DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women.
    Hasan ME; Matin M; Haque ME; Aziz MA; Millat MS; Uddin MS; Moghal MMR; Islam MS
    Cancer Med; 2021 Mar; 10(5):1829-1838. PubMed ID: 33586351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk.
    Gostout BS; Poland GA; Calhoun ES; Sohni YR; Giuntoli RL; McGovern RM; Sloan JA; Cha SS; Persing DH
    Gynecol Oncol; 2003 Mar; 88(3):326-32. PubMed ID: 12648582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women.
    Wu Y; Chen Y; Li L; Cao Y; Liu Z; Liu B; Du Z; Zhang Y; Chen S; Lin Z; Xu A
    Int J Cancer; 2006 Jun; 118(12):3006-11. PubMed ID: 16425277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Li T; Huang H; Liao D; Ling H; Su B; Cai M
    Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Susceptible and Protective Associations of HLA Alleles and Haplotypes with Cervical Cancer in South India.
    Rathika C; Murali V; Dhivakar M; Kamaraj R; Malini RP; Ramgopal S; Balakrishnan K
    Asian Pac J Cancer Prev; 2016; 17(5):2491-7. PubMed ID: 27268619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger.
    Nawa A; Nishiyama Y; Kobayashi T; Wakahara Y; Okamoto T; Kikkawa F; Suganuma N; Goto S; Kuzuya K; Tomoda Y
    Cancer; 1995 Jan; 75(2):518-21. PubMed ID: 7812922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Functional Polymorphism in the Promoter of miR-17-92 is Associated with a Reduced Risk of Cervical Squamous Cell Carcinoma.
    Huang J; Ni S; Tang R
    Reprod Sci; 2020 Jan; 27(1):87-92. PubMed ID: 32046383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
    Wang SS; Hildesheim A; Gao X; Schiffman M; Herrero R; Bratti MC; Sherman ME; Barnes WA; Greenberg MD; McGowan L; Mortel R; Schwartz PE; Zaino RJ; Glass AG; Burk RD; Karacki P; Carrington M
    J Infect Dis; 2002 Sep; 186(5):598-605. PubMed ID: 12195346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women.
    Datta A; Tuz Zahora F; Abdul Aziz M; Sarowar Uddin M; Ferdous M; Shalahuddin Millat M; Shahid Sarwar M; Abdul Barek M; Jafrin S; Nahar S; Safiqul Islam M
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107091. PubMed ID: 33069925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
    Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
    Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
    Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
    Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
    BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA-DQB1 and cervical cancer in Venezuelan women.
    Dao DD; Sierra-Torres CH; Robazetti SC; de Gomez MN; König R; Lema C; Lester LJ; Au WW; Tyring SK
    Gynecol Oncol; 2005 Feb; 96(2):349-54. PubMed ID: 15661220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some but not all of HLA-II alleles are associated with cervical cancer in Chinese women.
    Liang J; Xu A; Xie Y; Awonuga AO; Lin Z
    Cancer Genet Cytogenet; 2008 Dec; 187(2):95-100. PubMed ID: 19027490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A risk evaluation model of cervical cancer based on etiology and human leukocyte antigen allele susceptibility.
    Hu B; Tao N; Zeng F; Zhao M; Qiu L; Chen W; Tan Y; Wei Y; Wu X; Wu X
    Int J Infect Dis; 2014 Nov; 28():8-12. PubMed ID: 25223804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphotoxin-alpha polymorphism and the risk of cervical cancer in Japanese subjects.
    Niwa Y; Hirose K; Matsuo K; Tajima K; Ikoma Y; Nakanishi T; Nawa A; Kuzuya K; Tamakoshi A; Hamajima N
    Cancer Lett; 2005 Jan; 218(1):63-8. PubMed ID: 15639341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.
    Johnson LG; Schwartz SM; Malkki M; Du Q; Petersdorf EW; Galloway DA; Madeleine MM
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):199-207. PubMed ID: 21071541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inherited alterations of TGF beta signaling components in Appalachian cervical cancers.
    Knobloch TJ; Peng J; Hade EM; Cohn DE; Ruffin MT; Schiano MA; Calhoun BC; McBee WC; Lesnock JL; Gallion HH; Pollock J; Lu B; Oghumu S; Zhang Z; Sears MT; Ogbemudia BE; Perrault JT; Weghorst LC; Strawser E; DeGraffinreid CR; Paskett ED; Weghorst CM
    Cancer Causes Control; 2019 Oct; 30(10):1087-1100. PubMed ID: 31435875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.